HEADER BIOSYNTHETIC PROTEIN 25-FEB-18 6CIX TITLE LACTAM CYCLISED MIMETIC OF A FRAGMENT OF P21 COMPND MOL_ID: 1; COMPND 2 MOLECULE: P21; COMPND 3 CHAIN: B; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: RESIDUES K7 AND E11 HAVE BEEN COVALENTLY JOINED AS A COMPND 6 LACTAM SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS PIP-BOX MOTIF, P21, CONSTRAINED, PEPTIDOMIMETIC, BIOSYNTHETIC PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.L.WEGENER REVDAT 4 14-JUN-23 6CIX 1 REMARK REVDAT 3 29-AUG-18 6CIX 1 JRNL REVDAT 2 01-AUG-18 6CIX 1 JRNL REVDAT 1 04-JUL-18 6CIX 0 JRNL AUTH K.L.WEGENER,A.E.MCGRATH,N.E.DIXON,A.J.OAKLEY,D.B.SCANLON, JRNL AUTH 2 A.D.ABELL,J.B.BRUNING JRNL TITL RATIONAL DESIGN OF A 310-HELICAL PIP-BOX MIMETIC TARGETING JRNL TITL 2 PCNA, THE HUMAN SLIDING CLAMP. JRNL REF CHEMISTRY V. 24 11325 2018 JRNL REFN ISSN 1521-3765 JRNL PMID 29917264 JRNL DOI 10.1002/CHEM.201801734 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CIX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1000232828. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.90 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.4 MM ACR1, 0.1 MM DSS, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; 2D COSY; 1D REMARK 210 1H REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA, ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 ARG B 142 160.00 67.59 REMARK 500 2 TYR B 151 44.68 -82.19 REMARK 500 4 TYR B 151 77.81 -157.79 REMARK 500 5 ARG B 142 26.89 -140.46 REMARK 500 5 ARG B 143 -64.54 -92.04 REMARK 500 5 SER B 146 109.21 -56.99 REMARK 500 6 PHE B 150 -55.73 -142.40 REMARK 500 7 THR B 148 41.40 -83.54 REMARK 500 9 TYR B 151 84.98 -157.88 REMARK 500 10 GLN B 144 87.01 61.31 REMARK 500 10 SER B 146 107.04 -55.42 REMARK 500 11 ARG B 142 -62.62 -165.08 REMARK 500 11 GLN B 144 61.25 -106.35 REMARK 500 12 ARG B 140 -75.34 -83.57 REMARK 500 12 LYS B 141 26.77 -153.84 REMARK 500 15 MET B 147 21.29 -75.64 REMARK 500 15 THR B 148 38.50 -163.62 REMARK 500 16 TYR B 151 56.02 -158.77 REMARK 500 17 SER B 146 98.93 -60.11 REMARK 500 17 THR B 148 32.51 -82.29 REMARK 500 17 TYR B 151 83.25 65.22 REMARK 500 18 ARG B 142 71.51 -101.37 REMARK 500 18 GLN B 144 76.72 -111.87 REMARK 500 18 PHE B 150 49.05 -91.70 REMARK 500 19 ARG B 142 74.47 -100.38 REMARK 500 19 GLU B 149 29.50 -72.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6CEJ RELATED DB: PDB REMARK 900 14MER FRAGMENT OF THE P21 PROTEIN WITHOUT A LACTAM CONSTRAINT REMARK 900 RELATED ID: 6CIV RELATED DB: PDB REMARK 900 RELATED LACTAM CONSTRAINED PEPTIDE REMARK 900 RELATED ID: 30415 RELATED DB: BMRB REMARK 900 LACTAM CYCLISED MIMETIC OF A FRAGMENT OF P21 DBREF 6CIX B 139 152 PDB 6CIX 6CIX 139 152 SEQRES 1 B 14 GLY ARG LYS ARG ARG GLN LYS SER MET THR GLU PHE TYR SEQRES 2 B 14 HIS LINK NZ LYS B 145 CD GLU B 149 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1